FindTrial
Sign In

The effect of thalidomide on children with beta-thalassemia major: a retrospective study

The effect of thalidomide on children with beta-thalassemia major: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066013
Enrollment
Unknown
Registered
2022-11-22
Start date
2022-11-22
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thalassemia

Interventions

case series:N/A

Sponsors

Zigong First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of beta-thalassemia intermedia and major; 2. Aged 14-18 years; 3. Guardians have signed the informed consent form; 4. Not participating in other clinical research projects in three months before enrollment; 5. Not taking other drugs that interfered with the therapeutic effect.

Exclusion criteria

Exclusion criteria: 1. Combined with liver, kidney and heart dysfunction; 2. Combined with other types of anemia; 3. Combined with malignant tumor diseases or rheumatic immunological diseases.

Design outcomes

Primary

MeasureTime frame
hemoglobin;Transfusion;Hemoglobin composition;erythrocyte lifespan;—

Secondary

MeasureTime frame
LIver function;Iron Metabolism Indicators;Oxidation index;—

Countries

China

Contacts

Public ContactKun Yang

Zigong First People's Hospital

1759874951@qq.com+86 15181977603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026